These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1645830)
21. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320 [TBL] [Abstract][Full Text] [Related]
22. Is flumazenil an alternative for the treatment of hepatic encephalopathy? Reyes D; Barrera F Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356 [TBL] [Abstract][Full Text] [Related]
23. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850 [TBL] [Abstract][Full Text] [Related]
24. [Flumazenil in the treatment of hepatic encephalopathy]. Pintanel T; Font MM; García-Guasch R Med Clin (Barc); 1990 Jun; 95(4):157. PubMed ID: 2250539 [No Abstract] [Full Text] [Related]
26. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study. Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248 [TBL] [Abstract][Full Text] [Related]
30. Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy. Meier R; Gyr K; Scholer A Gastroenterology; 1991 Jul; 101(1):274-5. PubMed ID: 2044919 [No Abstract] [Full Text] [Related]
31. Flumazenil in the treatment of hepatic encephalopathy. Howard CD; Seifert CF Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621 [No Abstract] [Full Text] [Related]
36. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story. Jones EA Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022 [No Abstract] [Full Text] [Related]
37. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Basile AS; Jones EA; Skolnick P Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609 [No Abstract] [Full Text] [Related]
38. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases]. Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421 [No Abstract] [Full Text] [Related]
39. Endozepines in recurrent stupor. Cortelli P; Avallone R; Baraldi M; Zeneroli ML; Mandrioli J; Corsi L; Riva R; Tinuper P; Lugaresi E; Baruzzi A; Montagna P Sleep Med Rev; 2005 Dec; 9(6):477-87. PubMed ID: 16233983 [TBL] [Abstract][Full Text] [Related]
40. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis. Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]